Anaplastic Oligoastrocytoma
Information
- Disease name
- Anaplastic Oligoastrocytoma
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00303849 | Completed | Phase 1/Phase 2 | Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors | September 15, 2005 | March 12, 2021 |
| NCT01922076 | Completed | Phase 1 | Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas | September 3, 2013 | September 30, 2022 |
| NCT00884416 | Completed | Phase 1 | Sorafenib in Newly Diagnosed High Grade Glioma | March 2009 | March 2012 |
| NCT01156584 | Completed | Phase 1 | A Study of a Retroviral Replicating Vector Combined With a Prodrug Administered to Patients With Recurrent Malignant Glioma | July 2010 | August 18, 2016 |
| NCT01189266 | Completed | Phase 1/Phase 2 | Vorinostat and Radiation Therapy Followed by Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma | August 9, 2010 | September 30, 2021 |
| NCT01250470 | Completed | Phase 1 | Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma | September 5, 2012 | May 29, 2014 |
| NCT01380782 | Completed | Phase 2 | BIBF 1120 for Recurrent High-Grade Gliomas | May 2012 | July 2014 |
| NCT01470794 | Completed | Phase 1 | Study of a Retroviral Replicating Vector Combined With a Prodrug to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor | February 2012 | April 12, 2016 |
| NCT01522820 | Completed | Phase 1 | Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors | March 2012 | July 2016 |
| NCT03072134 | Completed | Phase 1 | Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma | April 24, 2017 | July 1, 2021 |
| NCT03043391 | Completed | Phase 1 | Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children | November 7, 2017 | March 23, 2022 |
| NCT02026271 | Completed | Phase 1 | A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma | June 2015 | August 2019 |
| NCT02015819 | Completed | Phase 1 | Genetically Modified Neural Stem Cells, Flucytosine, and Leucovorin for Treating Patients With Recurrent High-Grade Gliomas | October 7, 2014 | October 7, 2017 |
| NCT01985256 | Completed | Phase 1 | Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor | February 2014 | March 3, 2016 |
| NCT01847235 | Completed | Phase 2 | Temozolomide in Relapsed or Advanced Anaplastic Oligodendroglioma and Oligoastrocytoma: Single-arm, Phase II Trial | May 2013 | March 2016 |
| NCT05600491 | Recruiting | Phase 3 | A Phase III Study of Postoperative Early Temozolomide Treatment Plus STUPP Regimen for Newly Diagnosed GBM Multiforme | November 8, 2015 | December 1, 2025 |
| NCT01849952 | Recruiting | Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas | February 28, 2020 | May 2024 | |
| NCT02800486 | Recruiting | Phase 2 | Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA | May 2016 | May 2026 |
| NCT04623931 | Recruiting | Phase 2 | Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas | January 30, 2020 | December 31, 2026 |
| NCT01721577 | Terminated | Phase 1/Phase 2 | Phase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant Astrocytomas | December 2012 | December 2015 |
| NCT02168270 | Terminated | Phase 1 | Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma | June 16, 2014 | August 20, 2015 |
| NCT00035373 | Terminated | Eligibility Screening of Patients With Central Nervous System Tumors for the National Cancer Institute s (NCI) Clinical Research Protocols | April 19, 2002 | April 29, 2015 | |
| NCT02795364 | Unknown status | N/A | Study About the Validity of MRS-guided Resection on Prognosis High-grade Glioma Gliomas | June 2016 | May 2018 |
| NCT01656980 | Unknown status | Phase 3 | Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma | August 2012 | December 2014 |
| NCT01637753 | Unknown status | N/A | Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma | June 2012 | December 2013 |
| NCT01765088 | Unknown status | Phase 3 | A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas | September 2012 | December 2019 |
| NCT02629757 | Unknown status | Phase 3 | A Study on β-elemene as Maintain Treatment for Newly Diagnosed Malignant Gliomas | April 2015 | May 2023 |
| NCT01711580 | Withdrawn | Re-irradiation of High Grade Gliomas: a Quality of Life Study | March 2013 | September 2015 |
- OrphaNumber from OrphaNet (Orphanet)
- 251663